Core needle biopsies for determination of the microenvironment in individual tumours for longitudinal radiobiological studies

Radiotherapy and Oncology

Volumn 92, Issue 3, 2009, Pages 460-465

  Yaromina, Ala ^a   Eckardt, Anja ^a   Zips, Daniel ^a   Eicheler, Wolfgang ^a   Schuetze, Christina ^a   Thames, Howard ^b   Baumann, Michael ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Fractionated radiation; Human tumour xenograft; Local tumour control; Needle biopsy; Pimonidazole; Predictive assays; Tumour microenvironment

Indexed keywords

PIMONIDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPOXEMIA; MALE; MOUSE; NEEDLE BIOPSY; NONHUMAN; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; SQUAMOUS CELL CARCINOMA; TISSUE PERFUSION; TUMOR BIOPSY; TUMOR NECROSIS; TUMOR VASCULARIZATION;

EID: 69949151449     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.07.008     Document Type: Article

References (27)

1. Baumann M., and Krause M. Tumor biology's impact on clinical cure rates. In: Molls M., Vaupel P., Nieder C., and Anscher M.S. (Eds). The impact of tumor biology on cancer treatment and multidisciplinary strategies. 1st ed. (2009), Springer, Berlin 323-334
2. Baumann M., Krause M., and Hill R. Exploring the role of cancer stem cells in radioresistance. Nat Rev Cancer 8 (2008) 545-554
3. Bentzen S.M., and Tucker S.L. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 71 (1997) 531-542
4. Brahme A. Dosimetric precision requirements in radiation therapy. Acta Radiol Oncol 23 (1984) 379-391
5. Bussink J., Kaanders J.H., and van der Kogel A.J. Tumor hypoxia at the micro-regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers. Radiother Oncol 67 (2003) 3-15
6. Cline J.M., Rosner G.L., Raleigh J.A., and Thrall D.E. Quantification of CCI-103F labeling heterogeneity in canine solid tumors. Int J Radiat Oncol Biol Phys 37 (1997) 655-662
7. Dubois L., Douma K., Supuran C.T., et al. Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors. Radiother Oncol 83 (2007) 367-373
8. Efron B., and Tibshirani R. Bootstrap measures for standard errors, confidence intervals, and other measures of statistical accuracy. Stat Sci 1 (1986) 54-77
9. Eschmann S.M., Paulsen F., Bedeshem C., et al. Hypoxia-imaging with (18)F-misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer. Radiother Oncol 83 (2007) 406-410
10. Evans S.M., Du K.L., Chalian A.A., et al. Patterns and levels of hypoxia in head and neck squamous cell carcinomas and their relationship to patient outcome. Int J Radiat Oncol Biol Phys 69 (2007) 1024-1031
11. Evans S.M., and Koch C.J. Prognostic significance of tumor oxygenation in humans. Cancer Lett 195 (2003) 1-16
12. Horsman M.R., Khalil A.A., Siemann D.W., et al. Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation. Int J Radiat Oncol Biol Phys 29 (1994) 439-442
13. Howes A.E. An estimation of changes in the proportions and absolute numbers of hypoxic cells after irradiation of transplanted C3H mousemammary tumours. Br J Radiol 42 (1969) 441-447
14. Kaanders J.H., Bussink J., and van der Kogel A.J. Clinical studies of hypoxia modification in radiotherapy. Semin Radiat Oncol 14 (2004) 233-240
15. Kaanders J.H., Wijffels K.I., Marres H.A., et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62 (2002) 7066-7074
16. Kim I.H., and Brown J.M. Reoxygenation and rehypoxiation in the SCCVII mouse tumor. Int J Radiat Oncol Biol Phys 29 (1994) 493-497
17. 18F]-MISO in rodent tumor models. Radiother Oncol 89 (2008) 353-360
18. Moeller B.J., Richardson R.A., and Dewhirst M.W. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev 26 (2007) 241-248
19. Nordsmark M., Eriksen J.G., Gebski V., Alsner J., Horsman M.R., and Overgaard J. Differential risk assessments from five hypoxia specific assays: the basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. Radiother Oncol 83 (2007) 389-397
20. Nordsmark M., and Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57 (2000) 39-43
21. Overgaard J., Hansen H.S., Overgaard M., et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radiother Oncol 46 (1998) 135-146
22. 18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman Radiation Oncology Group Study 98.02. J Clin Oncol 24 (2006) 2098-2104
23. Rofstad E.K., and Maseide K. Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours. Int J Radiat Biol 75 (1999) 1377-1393
24. Sutherland R.M., Ausserer W.A., Murphy B.J., and Laderoute K.R. Tumor hypoxia and heterogeneity: challenges and opportunities for the future. Semin Radiat Oncol 6 (1996) 59-70
25. Walker A.M., and Suit H.D. Assessment of local tumor control using censored tumor response data. Int J Radiat Oncol Biol Phys 9 (1983) 383-386
26. Yaromina A., Krause M., Thames H., et al. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation. Radiother Oncol 83 (2007) 304-310
27. Yaromina A., Zips D., Thames H.D., et al. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol 81 (2006) 122-129